Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Clinical trial NCT06832085 · RECRUITING
Trial details
- NCT number
- NCT06832085
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2027-04-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.